CD44 and breast cancer: Several investigations reported that HA exhibited a high affinity for cell surface receptors, i.e., CD44 has emerged as a prevalent ligand to coat CSNPs to target breast cancer via facilitating the access of NPs into cells and enhancing the concentration of medicine within cancer cells via endocytosis [66,67].